The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Factor IX Deficiency Treatment Market Research Report 2025

Global Factor IX Deficiency Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1921520

No of Pages : 70

Ask Your Query
Synopsis
Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.
The global Factor IX Deficiency Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market during the forecast period. Factors such a low cost and high efficiency are the key contributors to the dominance of this segment in the global market.
This report aims to provide a comprehensive presentation of the global market for Factor IX Deficiency Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Deficiency Treatment.
Report Scope
The Factor IX Deficiency Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Factor IX Deficiency Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor IX Deficiency Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Takeda
Novo Nordisk
Biogen
CSL Behring
Segment by Type
Hemophilia B
Hemophilia B Inhibitors
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Factor IX Deficiency Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Factor IX Deficiency Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemophilia B
1.2.3 Hemophilia B Inhibitors
1.3 Market by Application
1.3.1 Global Factor IX Deficiency Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Factor IX Deficiency Treatment Market Perspective (2019-2030)
2.2 Factor IX Deficiency Treatment Growth Trends by Region
2.2.1 Global Factor IX Deficiency Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Factor IX Deficiency Treatment Historic Market Size by Region (2019-2024)
2.2.3 Factor IX Deficiency Treatment Forecasted Market Size by Region (2025-2030)
2.3 Factor IX Deficiency Treatment Market Dynamics
2.3.1 Factor IX Deficiency Treatment Industry Trends
2.3.2 Factor IX Deficiency Treatment Market Drivers
2.3.3 Factor IX Deficiency Treatment Market Challenges
2.3.4 Factor IX Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Factor IX Deficiency Treatment Players by Revenue
3.1.1 Global Top Factor IX Deficiency Treatment Players by Revenue (2019-2024)
3.1.2 Global Factor IX Deficiency Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Factor IX Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Factor IX Deficiency Treatment Revenue
3.4 Global Factor IX Deficiency Treatment Market Concentration Ratio
3.4.1 Global Factor IX Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Factor IX Deficiency Treatment Revenue in 2023
3.5 Factor IX Deficiency Treatment Key Players Head office and Area Served
3.6 Key Players Factor IX Deficiency Treatment Product Solution and Service
3.7 Date of Enter into Factor IX Deficiency Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Factor IX Deficiency Treatment Breakdown Data by Type
4.1 Global Factor IX Deficiency Treatment Historic Market Size by Type (2019-2024)
4.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2025-2030)
5 Factor IX Deficiency Treatment Breakdown Data by Application
5.1 Global Factor IX Deficiency Treatment Historic Market Size by Application (2019-2024)
5.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Factor IX Deficiency Treatment Market Size (2019-2030)
6.2 North America Factor IX Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Factor IX Deficiency Treatment Market Size by Country (2019-2024)
6.4 North America Factor IX Deficiency Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Factor IX Deficiency Treatment Market Size (2019-2030)
7.2 Europe Factor IX Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Factor IX Deficiency Treatment Market Size by Country (2019-2024)
7.4 Europe Factor IX Deficiency Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Factor IX Deficiency Treatment Market Size (2019-2030)
8.2 Asia-Pacific Factor IX Deficiency Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Factor IX Deficiency Treatment Market Size (2019-2030)
9.2 Latin America Factor IX Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Factor IX Deficiency Treatment Market Size by Country (2019-2024)
9.4 Latin America Factor IX Deficiency Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Factor IX Deficiency Treatment Market Size (2019-2030)
10.2 Middle East & Africa Factor IX Deficiency Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Factor IX Deficiency Treatment Introduction
11.1.4 Pfizer Revenue in Factor IX Deficiency Treatment Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Factor IX Deficiency Treatment Introduction
11.2.4 Takeda Revenue in Factor IX Deficiency Treatment Business (2019-2024)
11.2.5 Takeda Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Detail
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Factor IX Deficiency Treatment Introduction
11.3.4 Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2019-2024)
11.3.5 Novo Nordisk Recent Development
11.4 Biogen
11.4.1 Biogen Company Detail
11.4.2 Biogen Business Overview
11.4.3 Biogen Factor IX Deficiency Treatment Introduction
11.4.4 Biogen Revenue in Factor IX Deficiency Treatment Business (2019-2024)
11.4.5 Biogen Recent Development
11.5 CSL Behring
11.5.1 CSL Behring Company Detail
11.5.2 CSL Behring Business Overview
11.5.3 CSL Behring Factor IX Deficiency Treatment Introduction
11.5.4 CSL Behring Revenue in Factor IX Deficiency Treatment Business (2019-2024)
11.5.5 CSL Behring Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Factor IX Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hemophilia B
Table 3. Key Players of Hemophilia B Inhibitors
Table 4. Global Factor IX Deficiency Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Factor IX Deficiency Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Factor IX Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Factor IX Deficiency Treatment Market Share by Region (2019-2024)
Table 8. Global Factor IX Deficiency Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Factor IX Deficiency Treatment Market Share by Region (2025-2030)
Table 10. Factor IX Deficiency Treatment Market Trends
Table 11. Factor IX Deficiency Treatment Market Drivers
Table 12. Factor IX Deficiency Treatment Market Challenges
Table 13. Factor IX Deficiency Treatment Market Restraints
Table 14. Global Factor IX Deficiency Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Factor IX Deficiency Treatment Market Share by Players (2019-2024)
Table 16. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Deficiency Treatment as of 2023)
Table 17. Ranking of Global Top Factor IX Deficiency Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Factor IX Deficiency Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Factor IX Deficiency Treatment Product Solution and Service
Table 21. Date of Enter into Factor IX Deficiency Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Factor IX Deficiency Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Factor IX Deficiency Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Factor IX Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Factor IX Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Factor IX Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Factor IX Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Factor IX Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Factor IX Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Factor IX Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Factor IX Deficiency Treatment Product
Table 49. Pfizer Revenue in Factor IX Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Takeda Company Detail
Table 52. Takeda Business Overview
Table 53. Takeda Factor IX Deficiency Treatment Product
Table 54. Takeda Revenue in Factor IX Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 55. Takeda Recent Development
Table 56. Novo Nordisk Company Detail
Table 57. Novo Nordisk Business Overview
Table 58. Novo Nordisk Factor IX Deficiency Treatment Product
Table 59. Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 60. Novo Nordisk Recent Development
Table 61. Biogen Company Detail
Table 62. Biogen Business Overview
Table 63. Biogen Factor IX Deficiency Treatment Product
Table 64. Biogen Revenue in Factor IX Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 65. Biogen Recent Development
Table 66. CSL Behring Company Detail
Table 67. CSL Behring Business Overview
Table 68. CSL Behring Factor IX Deficiency Treatment Product
Table 69. CSL Behring Revenue in Factor IX Deficiency Treatment Business (2019-2024) & (US$ Million)
Table 70. CSL Behring Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Factor IX Deficiency Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Factor IX Deficiency Treatment Market Share by Type: 2023 VS 2030
Figure 3. Hemophilia B Features
Figure 4. Hemophilia B Inhibitors Features
Figure 5. Global Factor IX Deficiency Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Factor IX Deficiency Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Other Case Studies
Figure 10. Factor IX Deficiency Treatment Report Years Considered
Figure 11. Global Factor IX Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Factor IX Deficiency Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Factor IX Deficiency Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Factor IX Deficiency Treatment Market Share by Players in 2023
Figure 15. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Deficiency Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Factor IX Deficiency Treatment Revenue in 2023
Figure 17. North America Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Factor IX Deficiency Treatment Market Share by Country (2019-2030)
Figure 19. United States Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Factor IX Deficiency Treatment Market Share by Country (2019-2030)
Figure 23. Germany Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Factor IX Deficiency Treatment Market Share by Region (2019-2030)
Figure 31. China Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Factor IX Deficiency Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Factor IX Deficiency Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Factor IX Deficiency Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Factor IX Deficiency Treatment Business (2019-2024)
Figure 46. Takeda Revenue Growth Rate in Factor IX Deficiency Treatment Business (2019-2024)
Figure 47. Novo Nordisk Revenue Growth Rate in Factor IX Deficiency Treatment Business (2019-2024)
Figure 48. Biogen Revenue Growth Rate in Factor IX Deficiency Treatment Business (2019-2024)
Figure 49. CSL Behring Revenue Growth Rate in Factor IX Deficiency Treatment Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock